Inflation of diagnostic tests in hypertensive young adults: a need for diagnostic guideline?
Author:
Kirkpantur Alper1, Arici Mustafa1, Altun Bulent1, Turgan Cetin1
Affiliation:
1. 1Department of Internal Medicine, Nephrology Unit, Hacettepe University Faculty of Medicine, 06500, Ankara, Turkey
Abstract
AbstractThe cause of hypertension in young adults (age:18–29 years) is mostly a primary condition although secondary causes are frequent in this population. Clinical files of 100 patients were reviewed to evaluate the use of diagnostic tests after completion of diagnostic work-up for hypertension. Seventy-nine patients had primary hypertension while 21 patients had secondary hypertension. Renal imaging studies, serum levels of aldosterone and plasma renin activity, and screening tests for pheochromocytoma were more likely to be performed in patients younger than 24 years, in female patients and in patients without familial history of hypertension in primary hypertensive patients (p<0.05). Renal imaging studies and screening tests for pheochromocytoma were done more frequently in patients with Stage 2 hypertension (p<0,05). Among secondary hypertensives, renal imaging studies and renal biopsy were more ordered in patients younger than 24 years, in female patients, in patients with Stage 2 hypertension and in patients without family history for hypertension (p<0.05). Mean body mass index was higher in patients with primary hypertension than patients with secondary hypertension (p<0.05). Seventy patients (70%) had undergone several screening interventions with negative results. In conclusion, a simple, stepwise diagnostic evaluation would greatly benefit the management of young hypertensives.
Publisher
Walter de Gruyter GmbH
Reference25 articles.
1. Lurbe E., Torro I., Alvarez V., Nawrot T., Paya R., Redon J., et al., Prevalence, persistence, and clinical significance of masked hypertension in youth, Hypertension, 2005, 45, 493–498. 2. Williams C.L., Hayman L.L., Daniels S.R., Robinson T.N., Steinberger J., Paridon S., et al., Cardiovascular health in childhood. A statement for health professionals from the committee on atherosclerosis, hypertension, and obesity in the young (AHOY) of the council on cardiovascular disease in the young, American Heart Association, Circulation, 2002, 106, 143–160. 3. Burt V.L., Whelton P., Roccella E.J., Brown C., Cutler J.A., Higgins M.,et al., Prevalance of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension, 1995, 25, 305–313. 4. Altun B., Arici M., Nergizoğlu G., Derici U., Karatan O., Turgan C., et al.; for the Turkish Society of Hypertension and Renal Diseases, Prevalance, awareness, treatment and control of hypertension in Turkey (the PatenT study) in 2003, J. Hypertens., 2005, 23, 1817–1823. 5. Slovut D.P., Olin J.W., Fibromuscular dysplasia, N. Engl. J. Med., 2004, 350, 1862–1871.
|
|